9DZ-38902-89477
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 208 / MD
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
SF4-97201-29902
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2021-02-09
Registered in v-safe
-
2021-02-09
Dose 1 — Pfizer-BioNTech
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-23
-
2021-03-02
Dose 2 — Pfizer-BioNTech
- 2021-03-02
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-06-01
- 2021-08-31
-
2022-03-04
Survey response — 12 months, dose 2MedDRA: Dermatitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: DermatitisMedDRA releases: 2024-11 · check-in free text available
-
2022-03-04
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-08
-
2022-03-08
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-09-11
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-11
- 2022-09-12
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-27
-
2022-10-02
Survey response — day 21, dose 3MedDRA: Abortion spontaneous — Feeling: GoodFree text: Had a miscarriageMedDRA releases: 2024-11 · check-in free text available
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-12-11
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-09 | Pfizer-BioNTech | |
| 2 | 2021-03-02 | Pfizer-BioNTech | |
| 3 | 2022-09-11 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-04 | Successful 2022-03-08 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 11 — 12 months, dose 2
Symptoms: Dermatitis
Release 12 — day 21, dose 3
Symptoms: Had a miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Dermatitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release